Concepedia

Sara Duhachek-Muggy

SD

12

Publications

433

Citations

12

H-Index

2012

Active since

Affiliations

University of California, Los Angeles(Current)

Kansas State University

UCLA Jonsson Comprehensive Cancer Center

Sara Duhachek-Muggy is an author at University of California, Los Angeles specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2012–2020

12

Publications

12

Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer

Le Zhang, Milana Bochkur Dratver, Taha Yazal et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 71 citations

, , +7

The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma

Kruttika Bhat, Mohammad Saki, Erina Vlashi et al. · Proceedings of the National Academy of Sciences · 2020 · 70 citations · Full text

, , +19

Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer

Sara Duhachek-Muggy, Yue Qi, Randi Wise et al. · Molecular Cancer · 2017 · 68 citations · Full text

ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer

Sara Duhachek-Muggy, Anna Żółkiewska · BMC Cancer · 2015 · 43 citations · Full text

An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer

Hui Li, Sara Duhachek-Muggy, Yue Qi et al. · Breast Cancer Research and Treatment · 2012 · 37 citations · Full text

, , +7

Rows per page

1–5 of 12